ABSTRACT Introduction Systemic AL amyloidosis (ALA) is a clonal plasma cell (PC) disease
characterized by deposition of amyloid fibrils in different organs and tissues. Traditionally …

The presentation and course of AL amyloidosis is characterized by significant heterogeneity,
depending on the organ tropism of the amyloidogenic light chain, the severity of organ …

Background Characteristics of AL amyloidosis across Asia are not well-described in the
literature. Thus, we overviewed the incidence and disease characteristics of AL amyloidosis …

In amyloid light-chain (AL) amyloidosis, a small plasma-cell clone, or less frequently a
mature B-cell clone, produces toxic monoclonal light chains that can be deposited in the …

Abstract Purpose of Review Light chain (AL) amyloidosis is an insidious progressive
disease which results in significant morbidity and inevitable mortality if not diagnosed and …

Systemic Light chain (AL) amyloidosis is a monoclonal plasma cell proliferative disorder
characterized by deposition of amyloidogenic monoclonal light chain fragments causing …

Amyloid light chain (AL) amyloidosis is among the more common and more severe of the
amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell …

Introduction: AL amyloidosis (AL) is a plasma cell disorder characterized by life-threatening
vital organ dysfunction resulting in nearly a third of patients dying within the first year of …

The combination of cyclophosphamide/bortezomib/dexamethasone (CyBorD) showed early
promise of high rates of hematologic responses tempered by studies showing the inability to …

Author contributions and disclosures: VS designed the study, performed data analysis, and
wrote manuscript. BB, EG and AS collected the data. LM, TJ, NB, AS, JMS, and VS …